The Independent Uganda: You get the Truth we Pay the Price
Johannesberg, South Africa | THE INDEPENDENT | Food and Drug Administration (FDA) approval of injectable lenacapavir (LEN) for the prevention of HIV as pre-exposure prophylaxis (PrEP). LEN, developed by Gilead Sciences, is a twice-yearly injectable PrEP option that showed nearly complete protection against HIV in the landmark PURPOSE 1 and 2 …
Read More »Byanyima wants Trump to fund injectable Lenacapavir for PrEP
